chugai pharmaceutical co ltd
(4519:Tokyo Stock Exchange)
Jean-Jacques Garaud M.D.
Former Director, Chugai Pharmaceutical Co. Ltd.
|Age||Total Calculated Compensation||This person is connected to 19 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Jean-Jacques Garaud, M.D served as an Advisor of Inserm Transfert Initiative. Dr. Garaud served as Head of Pharmaceutical Research at Roche Holding AG until July 5, 2014. He served as the Head of Roche Pharma Research and Early Development of Roche Holding AG (also known as F. Hoffmann-La Roche) since January 1, 2010 until 2012. He served as the Head of Global Pharma Development for Roche Holding AG. Prior to joining F. Hoffmann-La Roche Ltd. in 2007, Dr. Garaud ...
1-1 Nihonbashi-Muromachi 2-ChomePhone: 81 3 3281 6611
Tokyo, -- 103-8324
Fax: 81 3 3281 6607
Board Members Memberships*
Independent Non-Executive Director, Chairman of Remuneration Committee, Member of Audit Committee and Member of Nomination Committee
Université de la Sorbonne - Université de Paris
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Joseph Jimenez Jr., MBA||Chief Executive Officer|
|Olivier Brandicourt||Chief Executive Officer and Director|
|--||Compensation as of Fiscal Year 2014.|